2016•Unpublished venueRequires access

Research progress of the prognosis of chronic lymphocytic leukemia: reports from the 57th American Society of Hematology annual meeting

Fangtian Wu, Wei Xu

Abstract

Chronic lymphocytic leukemia (CLL) is a kind of malignant B-cell chronic lymphoproliferative disorder with highly heterogeneous clinical courses. Due to the recent advances in immunology, cellular genetics and molecular biology, several prognostic markers based on genetic, phenotypic, and molecular biology characteristics of CLL cells have emerged in the past decade. This article reviews the reports from the 57th American Society of Hematology (ASH) annual meeting on the progress of the prognosis of CLL. Key words: Leukemia, lymphocytic, chronic; Prognosis; American Society of Hematology annual meeting

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Hematology, Chronic lymphocytic leukemia, Internal medicine, Oncology, Medicine, Immunology, Leukemia